Even with sprays, irrigations and pills, a staggering 80% of people can't find relief. Now, there's a potentially ...

MannKind Corporation (($MNKD)) announced an update on their ongoing clinical study. Study Overview: MannKind Corporation is conducting a Phase 3 ...

These are abbreviated use instructions, please remember to read the complete instructions that are packaged with your AEROCHAMBER2GO® Chamber. PLATTSBURGH, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- ...

Tyvaso significantly improved a measure of lung function for IPF patients in a Phase 3 trial, which top-line data showed met ...

To this session of the Morgan Stanley Global Healthcare Conference. I'm excited to welcome the team from 4D Molecular Therapeutics. Let me just get through a quick disclosure before we get started.

Shares of United Therapeutics UTHR surged 33% on Tuesday after it announced positive top-line results from the late-stage ...

Get the latest on MannKind’s IPF drug pipeline, TETON data, acquisitions, and Afrezza updates from the 2025 Cantor Global Healthcare Conference.

The refreshed analysis, conducted by a third-party advanced analytics provider, accessed a more current and comprehensive view of patient and healthcare claims data using open and closed source ...